Tourmaline Bio, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tourmaline Bio, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Tourmaline Bio, Inc. Return On Equity for the quarter ending June 30, 2024 was -19 %, a 28.2% increase year-over-year.
  • Tourmaline Bio, Inc. annual Return On Equity for 2023 was -60.5 %, a 370% decline from 2022.
  • Tourmaline Bio, Inc. annual Return On Equity for 2022 was -12.9 %, a 67.9% increase from 2021.
  • Tourmaline Bio, Inc. annual Return On Equity for 2021 was -40.2 %, a 152% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -19 +7.44 +28.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -29.1 -19.1 -192% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.5 -47.6 -370% Oct 1, 2023 Dec 31, 2023
Q3 2023 37.3 +81.4 Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.4 +10.3 +28.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -9.96 +20.4 +67.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -12.9 +27.3 +67.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44.1 -7.26 -19.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -36.7 +53.1 +59.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.3 -106 -140% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.2 -117 -152% Oct 1, 2021 Dec 31, 2021
Q3 2021 -36.8 Jul 1, 2021 Sep 30, 2021
Q2 2021 -89.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 76 Jan 1, 2021 Mar 31, 2021
Q4 2020 76.8 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.